Charles River to make Casgevy; Rentschler extends collab with ‘major client’; Andelyn works with Ultragenyx

2023-12-21

基因疗法

Welcome to Endpoints News’ manufacturing news briefs, where we bring you essential updates on new builds, collaborations, recalls and more. Charles River Laboratories said Monday it will manufacture Vertex and CRISPR Therapeutics’ Casgevy, with its Memphis site having gone through audits by the FDA and EMA. CDMO RoslinCT also manufactures the gene editing therapy. CDMO Rentschler Biopharma said that it has a “ major client ” for its manufacturing site in Milford, MA, with the facility set to go live in the second half of next year. The manufacturer noted Wednesday it will produce its “longstanding” client’s clinical-stage protein therapeutic for cancer in the US, after previously producing the same asset in Laupheim, Germany, for early-phase investigation.

更多内容，请访问原始网站

文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。

机构